Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy
Status:
Completed
Trial end date:
2020-06-21
Target enrollment:
Participant gender:
Summary
The investigators aim at evaluating the efficacy of bovine lactoferrin addition to H. Pylori
eradication regimens. 400 randomly distributed participants will be assigned to one of four
treatment regimens of H. Pylori (standard triple therapy, standard triple therapy plus bovine
lactoferrin, sequential therapy, or sequential therapy plus bovine lactoferrin), and
eradication rates will be evaluated among the four groups.